GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

BioAdaptives BDPT · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

-12.94%

Close of 5 Nov 2026, in USD

BioAdaptives annual report

Filed with the US Securities and Exchange Commission

10-K

The latest annual report covers the year to 31 Dec 2025, filed on 14 Apr 2026.

Read the 10-K on SEC.gov ↗

Five-year highlights

In USD.

FY2025FY2024FY2023FY2022FY2021
Revenue$18,278$12,669$28,565$17,176$19,776
Operating income−$1.0m−$602,000−$229,000−$422,000−$636,000
Net income−$1.6m−$899,000−$712,000−$896,000−$1.1m
Free cash flow−$534,025−$249,520−$223,776−$227,259−$158,651
Total assets$225,901$261,885$103,998$37,314$148,585
Shareholders' equity−$2.1m−$1.5m−$1.6m−$1.5m−$1.1m

Filings

Newest first, from SEC EDGAR

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.